Mike Ambrogi joined Novocure in 2006 and serves as Chief Operating Officer. Mike has overall responsibility for Novocure’s ongoing clinical, manufacturing, and service activities worldwide. Mike was previously the General Manager of Deka Research and Development, inventor Dean Kamen’s R&D firm. Mike led Deka’s teams on breakthrough products including the Baxter HomeChoice peritoneal dialysis machine, the Davol Hydroflex surgical irrigation device, the Cordis Crowne Stent, and the J&J IBOT 3000 mobility system. Earlier in his career, Mike was a consultant with McKinsey & Company. Mike holds a S.B. in mechanical engineering from the Massachusetts Institute of Technology (MIT).